Combination capecitabine and bevacizumab in the treatment of metastatic hepatic epithelioid hemangioendothelioma

Augustine Lau, Steve Malangone, Myke Green, Ambuga Badari, Kathryn Clarke, Emad - Elquza

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Hepatic epithelioid hemangioendothelioma (HEHE) is a rare, often misdiagnosed vascular neoplasm with clinical behaviors that range from indolent to highly aggressive. Even when the appropriate diagnosis is achieved, the best treatment for HEHE has not been defined or standardized, further complicating the care of these patients. We present a diagnostically challenging case of HEHE where we utilized capecitabine and bevacizumab as another novel treatment option.

Original languageEnglish (US)
Pages (from-to)229-236
Number of pages8
JournalTherapeutic Advances in Medical Oncology
Volume7
Issue number4
DOIs
StatePublished - Jul 19 2015

Fingerprint

Epithelioid Hemangioendothelioma
Liver
Vascular Neoplasms
Diagnostic Errors
Patient Care
Therapeutics
Capecitabine
Bevacizumab

Keywords

  • bevacizumab
  • capecitabine
  • epithelioid
  • hemangioendothelioma
  • heptatic
  • metastatic

ASJC Scopus subject areas

  • Oncology

Cite this

Combination capecitabine and bevacizumab in the treatment of metastatic hepatic epithelioid hemangioendothelioma. / Lau, Augustine; Malangone, Steve; Green, Myke; Badari, Ambuga; Clarke, Kathryn; Elquza, Emad -.

In: Therapeutic Advances in Medical Oncology, Vol. 7, No. 4, 19.07.2015, p. 229-236.

Research output: Contribution to journalArticle

Lau, Augustine ; Malangone, Steve ; Green, Myke ; Badari, Ambuga ; Clarke, Kathryn ; Elquza, Emad -. / Combination capecitabine and bevacizumab in the treatment of metastatic hepatic epithelioid hemangioendothelioma. In: Therapeutic Advances in Medical Oncology. 2015 ; Vol. 7, No. 4. pp. 229-236.
@article{e095c6a26d504cd79edc416ad86e951b,
title = "Combination capecitabine and bevacizumab in the treatment of metastatic hepatic epithelioid hemangioendothelioma",
abstract = "Hepatic epithelioid hemangioendothelioma (HEHE) is a rare, often misdiagnosed vascular neoplasm with clinical behaviors that range from indolent to highly aggressive. Even when the appropriate diagnosis is achieved, the best treatment for HEHE has not been defined or standardized, further complicating the care of these patients. We present a diagnostically challenging case of HEHE where we utilized capecitabine and bevacizumab as another novel treatment option.",
keywords = "bevacizumab, capecitabine, epithelioid, hemangioendothelioma, heptatic, metastatic",
author = "Augustine Lau and Steve Malangone and Myke Green and Ambuga Badari and Kathryn Clarke and Elquza, {Emad -}",
year = "2015",
month = "7",
day = "19",
doi = "10.1177/1758834015582206",
language = "English (US)",
volume = "7",
pages = "229--236",
journal = "Therapeutic Advances in Medical Oncology",
issn = "1758-8340",
publisher = "SAGE Publications Inc.",
number = "4",

}

TY - JOUR

T1 - Combination capecitabine and bevacizumab in the treatment of metastatic hepatic epithelioid hemangioendothelioma

AU - Lau, Augustine

AU - Malangone, Steve

AU - Green, Myke

AU - Badari, Ambuga

AU - Clarke, Kathryn

AU - Elquza, Emad -

PY - 2015/7/19

Y1 - 2015/7/19

N2 - Hepatic epithelioid hemangioendothelioma (HEHE) is a rare, often misdiagnosed vascular neoplasm with clinical behaviors that range from indolent to highly aggressive. Even when the appropriate diagnosis is achieved, the best treatment for HEHE has not been defined or standardized, further complicating the care of these patients. We present a diagnostically challenging case of HEHE where we utilized capecitabine and bevacizumab as another novel treatment option.

AB - Hepatic epithelioid hemangioendothelioma (HEHE) is a rare, often misdiagnosed vascular neoplasm with clinical behaviors that range from indolent to highly aggressive. Even when the appropriate diagnosis is achieved, the best treatment for HEHE has not been defined or standardized, further complicating the care of these patients. We present a diagnostically challenging case of HEHE where we utilized capecitabine and bevacizumab as another novel treatment option.

KW - bevacizumab

KW - capecitabine

KW - epithelioid

KW - hemangioendothelioma

KW - heptatic

KW - metastatic

UR - http://www.scopus.com/inward/record.url?scp=84931475651&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84931475651&partnerID=8YFLogxK

U2 - 10.1177/1758834015582206

DO - 10.1177/1758834015582206

M3 - Article

AN - SCOPUS:84931475651

VL - 7

SP - 229

EP - 236

JO - Therapeutic Advances in Medical Oncology

JF - Therapeutic Advances in Medical Oncology

SN - 1758-8340

IS - 4

ER -